Scientists Identify Mushroom Behind ‘Tiny People’ Hallucinations

University of Utah researchers confirmed through DNA sequencing that the wild mushroom species Lanmaoa asiatica causes “Lilliputian hallucinations”—vivid visions of tiny humans interacting with the physical environment—after being consumed undercooked in Southwest China and the northern Philippines.

For nearly a century, medical science struggled to explain why people across distant regions reported seeing 6-inch-tall human figures after consuming specific wild mushrooms. Historical inquiries stretching back to the 1930s in Papua New Guinea and subsequent investigations in the 1950s and 1960s—which even involved isolating compounds with Albert Hofmann—failed to uncover known psychoactive agents like psilocybin within these fungi. This led earlier generations of researchers to dismiss the phenomenon as a purely socio-cultural construct. However, new genetic analysis has shifted that clinical consensus toward a distinct biological reality.

In Plain English: The Clinical Takeaway

• The Core Finding: Eating undercooked Lanmaoa asiatica mushrooms triggers visual disturbances where humans appear miniature, a phenomenon historically termed “Lilliputian hallucinations.”
• The Biochemical Puzzle: Laboratory analyses confirm the mushroom lacks traditional psychoactive molecules like psilocybin, pointing instead toward a novel hallucinogenic compound.
• Global Health Context: Known locally as Jian shou qing in Yunnan and Sedesdem in the Philippines, these regional delicacies require thorough cooking to prevent neurological toxicity.

Unraveling a Decades-Long Neurological Mystery

The investigation into these bizarre visual anomalies began in earnest during the 1930s when Western scientists documented “mushroom madness” in Papua New Guinea. Anthropologists and mycologists spent decades examining bolete mushrooms in the Boletaceae family, yet standard chemical assays repeatedly returned negative results for known hallucinogens. Even pioneers of psychedelic chemistry could not locate an active pharmacological agent, causing academic interest to wane by the end of the 1960s.

The trajectory shifted when modern field researchers tracked contemporary reports from Yunnan, Southwest China, and later connected them with accounts from an Indigenous community in the Philippines’ remote Northern Cordillera region. Colin Domnauer, a doctoral student at the University of Utah, and Bryn Dentinger, a mycologist at the University of Utah and the Natural History Museum of Utah, published findings in the journal Mycologia on June 5, 2026. By utilizing DNA sequencing on collected specimens, the team verified that Lanmaoa asiatica was the common biological denominator across these geographically isolated outbreaks.

Geographic Distribution and the Mechanism of Preparation

In Southwest China’s Yunnan province, the mushroom is widely traded in markets ranging from small street blocks to the massive wild mushroom markets in Kunming, where upwards of 200 species of edible fungi are sold. Locals refer to the species as Jian shou qing, translating to “turns blue in the hand,” reflecting how the flesh rapidly oxidizes and changes color upon contact. Similarly, in the Northern Cordillera of the Philippines, local populations consume a wild species known locally as “Sedesdem.”

Photo: attheu.utah.edu

Across these regions, the neurotoxic visual effects are strictly tied to preparation technique. When thoroughly cooked, these mushrooms are safely consumed. When undercooked, however, they activate a specific neurochemical cascade that alters visual processing. This discovery opens new avenues for neurological research into how the central nervous system shapes perception and consciousness.

Key Characteristics of the Lilliputian Hallucinogenic Mushroom Species

Parameter	Clinical & Mycological Details
Scientific Classification	Lanmaoa asiatica (Family: Boletaceae)
Geographic Range	Southwest China (Yunnan) and Northern Philippines (Cordillera region)
Local Names	Jian shou qing (China); Sedesdem (Philippines); historically “Nonda” (Papua New Guinea)
Active Compounds	Unknown novel hallucinogenic compound (absent of psilocybin)
Clinical Presentation	Lilliputian hallucinations (vivid visions of miniature humans interacting with surroundings)
Primary Risk Factor	Incomplete thermal processing (consuming undercooked specimens)

Contraindications & When to Consult a Doctor

Future Directions in Neuropharmacology

The identification of an entirely new hallucinogenic compound within Lanmaoa asiatica provides pharmacologists with a novel tool for investigating brain function. It offers researchers a unique window into how the brain shapes perception and consciousness. Understanding how this unknown molecule interacts with neural circuits may ultimately shed light on neurological disease.

Disclaimer: This article is for informational purposes only and does not substitute for professional medical advice, diagnosis, or treatment.